Latest Biologic Stories
Expands rHuPH20 Production SAN DIEGO, Oct. 20, 2014 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that the U.S.
SAN DIEGO, Oct. 20, 2014 /PRNewswire/ -- AnaptysBio, Inc., a leader in the discovery and development of therapeutic antibodies, today announced the appointment of Marco Londei, M.D.
NEW YORK, Oct.
BEIJING, Oct. 17, 2014 /PRNewswire/ -- China Biologic Products, Inc.
ST. LOUIS, Oct.
Introduces Chairman Gewanter, shows support for BQ proposal GENEVA, Oct.
-- Mark Pimentel, M.D., FRCP(C), of Cedars-Sinai Medical Center Serves as Chairman -- ROCKVILLE, Md., Oct.
Selexis has promoted director of European business development, Marco Bocci, PhD, PharmD, to Vice President, European Licensing and Business Development for Europe. Geneva,
-- CIAO!(TM) Technology Maximizes Selectivity of Conditionally Active Antibodies -- SAN DIEGO, Oct.
- The practice of two or more parties jointly purchasing all or part of a butchered cow and dividing the meat between them.